A Kagramanova

716 total citations
46 papers, 108 citations indexed

About

A Kagramanova is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, A Kagramanova has authored 46 papers receiving a total of 108 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 28 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in A Kagramanova's work include Inflammatory Bowel Disease (35 papers), Microscopic Colitis (22 papers) and Autoimmune and Inflammatory Disorders (6 papers). A Kagramanova is often cited by papers focused on Inflammatory Bowel Disease (35 papers), Microscopic Colitis (22 papers) and Autoimmune and Inflammatory Disorders (6 papers). A Kagramanova collaborates with scholars based in Russia, United States and South Korea. A Kagramanova's co-authors include O. V. Knyazev, А И Парфенов, А. V. Veselov, Orlova Nv, E. А. Belousova, Л. С. Круглова, А. N. Lvov, Marina Koroleva, М. В. Шапина and И. Г. Бакулин and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Gastroenterology and Inflammatory Bowel Diseases.

In The Last Decade

A Kagramanova

41 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Kagramanova Russia 6 73 63 28 25 13 46 108
Chris Hawkey United Kingdom 2 42 0.6× 29 0.5× 33 1.2× 17 0.7× 4 0.3× 3 106
Laurent Peyrin-Biroulet France 7 102 1.4× 66 1.0× 31 1.1× 41 1.6× 4 0.3× 43 151
Claire Liefferinckx Belgium 8 181 2.5× 136 2.2× 83 3.0× 55 2.2× 12 0.9× 23 230
Beata Gawdis-Wojnarska Germany 4 133 1.8× 94 1.5× 108 3.9× 19 0.8× 9 0.7× 5 183
Peter M. Irving United Kingdom 3 162 2.2× 121 1.9× 51 1.8× 45 1.8× 4 0.3× 12 186
Laura Cantoro Italy 8 113 1.5× 88 1.4× 26 0.9× 76 3.0× 7 0.5× 10 178
Laura Loy Italy 8 106 1.5× 68 1.1× 49 1.8× 41 1.6× 2 0.2× 22 166
Seiji Yokoyama Japan 5 39 0.5× 94 1.5× 108 3.9× 51 2.0× 9 0.7× 8 212
Shaohong Yang United States 8 73 1.0× 43 0.7× 49 1.8× 26 1.0× 2 0.2× 16 174
Ana Isabel Cordeiro Portugal 6 32 0.4× 28 0.4× 70 2.5× 45 1.8× 9 0.7× 22 166

Countries citing papers authored by A Kagramanova

Since Specialization
Citations

This map shows the geographic impact of A Kagramanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Kagramanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Kagramanova more than expected).

Fields of papers citing papers by A Kagramanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Kagramanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Kagramanova. The network helps show where A Kagramanova may publish in the future.

Co-authorship network of co-authors of A Kagramanova

This figure shows the co-authorship network connecting the top 25 collaborators of A Kagramanova. A scholar is included among the top collaborators of A Kagramanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Kagramanova. A Kagramanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Knyazev, O. V., et al.. (2024). Efficacy and safety of dual therapy - biological and small molecules in patients with ulcerative colitis. Experimental and Clinical Gastroenterology. 5–12.
3.
Парфенов, А И, et al.. (2023). Modern concept of differential diagnosis of colitis: from G.F. Lang to the present day. A review. Terapevticheskii arkhiv. 95(12). 1022–1030. 1 indexed citations
4.
Knyazev, O. V., et al.. (2022). Efficacy and safety of ustekinumab therapy in patients with Crohn’s disease. Real clinical practice. Meditsinskiy sovet = Medical Council. 105–116. 1 indexed citations
5.
Kagramanova, A, et al.. (2022). CROHN'S DISEASE. TO THE 90th ANNIVERSARY OF THE DESCRIPTION. Problems of Social Hygiene Public Health and History of Medicine. 30(s1). 1162–1166. 1 indexed citations
6.
Knyazev, O. V., et al.. (2022). Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases. Terapevticheskii arkhiv. 94(2). 172–179. 1 indexed citations
7.
Knyazev, O. V., A Kagramanova, & А И Парфенов. (2021). Ulcerative colitis. To the 180th anniversary of the description by Karl Rokytansky. Terapevticheskii arkhiv. 93(12). 1564–1568. 1 indexed citations
8.
9.
Knyazev, O. V., et al.. (2021). Is histological remission of ulcerative colitis achievable?. Terapevticheskii arkhiv. 93(8). 975–981. 1 indexed citations
10.
11.
Belousova, E. А., И. Г. Бакулин, А. V. Veselov, et al.. (2019). EXPERIENCE OF TOFACITINIB USING IN THERAPY OF ULCERATIVE COLITIS IN REAL CLINICAL PRACTICE. Koloproktologia. 18(4). 86–99. 9 indexed citations
12.
Knyazev, O. V., et al.. (2019). O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov. SHILAP Revista de lepidopterología. 91(4). 53–61. 6 indexed citations
13.
14.
Knyazev, O. V., et al.. (2018). Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice. Terapevticheskii arkhiv. 90(6). 74–80. 3 indexed citations
15.
Парфенов, А И, et al.. (2018). Personalized medicine in the treatment of inflammatory bowel diseases. Terapevticheskii arkhiv. 90(2). 4–11. 1 indexed citations
16.
Knyazev, O. V. & A Kagramanova. (2017). THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE. Meditsinskiy sovet = Medical Council. 108–117. 1 indexed citations
17.
Knyazev, O. V., et al.. (2017). Efficacy of adalimumab for Crohn’s disease in real clinical practice. Terapevticheskii arkhiv. 89(2). 20–27. 2 indexed citations
18.
Knyazev, O. V., et al.. (2016). P526. Sampling not at trough: adalimumab serum drug and antibody levels remain relatively stable in between injections. Journal of Crohn s and Colitis. 10(suppl 1). S367.2–S368. 2 indexed citations
19.
Khatkov, Igor, et al.. (2016). Current principles in the screening, diagnosis, and therapy of colorectal cancer. Terapevticheskii arkhiv. 88(2). 90–90. 3 indexed citations
20.
Knyazev, O. V., et al.. (2016). Long-term infliximab therapy for ulcerative colitis in real clinical practice. Terapevticheskii arkhiv. 88(8). 46–52. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Hawkey Breakdown of academic impact, for papers by Laurent Peyrin-Biroulet Breakdown of academic impact, for papers by Claire Liefferinckx Breakdown of academic impact, for papers by Beata Gawdis-Wojnarska Breakdown of academic impact, for papers by Peter M. Irving Breakdown of academic impact, for papers by Laura Cantoro Breakdown of academic impact, for papers by Laura Loy Breakdown of academic impact, for papers by Seiji Yokoyama Breakdown of academic impact, for papers by Shaohong Yang Breakdown of academic impact, for papers by Ana Isabel Cordeiro
Rankless by CCL
2026